MANFREDINI, Rossella
 Distribuzione geografica
Continente #
NA - Nord America 15.972
EU - Europa 7.395
AS - Asia 6.448
SA - Sud America 899
AF - Africa 118
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 18
Totale 30.882
Nazione #
US - Stati Uniti d'America 15.774
GB - Regno Unito 2.508
CN - Cina 1.891
SG - Singapore 1.878
IT - Italia 1.525
HK - Hong Kong 1.204
SE - Svezia 939
BR - Brasile 742
DE - Germania 573
RU - Federazione Russa 404
VN - Vietnam 373
FI - Finlandia 298
FR - Francia 267
KR - Corea 254
UA - Ucraina 254
TR - Turchia 236
CA - Canada 136
ID - Indonesia 134
IN - India 129
BG - Bulgaria 118
NL - Olanda 76
SI - Slovenia 65
PL - Polonia 63
JP - Giappone 59
AR - Argentina 56
BE - Belgio 52
ZA - Sudafrica 50
BD - Bangladesh 48
MX - Messico 42
IE - Irlanda 40
IR - Iran 39
LT - Lituania 39
ES - Italia 34
EC - Ecuador 32
IQ - Iraq 32
CZ - Repubblica Ceca 29
AU - Australia 28
PK - Pakistan 25
AT - Austria 21
CO - Colombia 21
TW - Taiwan 18
CH - Svizzera 16
KE - Kenya 16
MY - Malesia 16
CL - Cile 15
MA - Marocco 15
AE - Emirati Arabi Uniti 13
EU - Europa 13
IL - Israele 13
UZ - Uzbekistan 13
EG - Egitto 12
QA - Qatar 12
PT - Portogallo 11
SA - Arabia Saudita 10
PY - Paraguay 9
VE - Venezuela 9
RO - Romania 8
NP - Nepal 7
PE - Perù 7
PH - Filippine 7
TN - Tunisia 7
AL - Albania 6
DK - Danimarca 6
DZ - Algeria 6
LU - Lussemburgo 6
NO - Norvegia 6
GR - Grecia 5
HU - Ungheria 5
JM - Giamaica 5
AM - Armenia 4
DO - Repubblica Dominicana 4
GE - Georgia 4
KW - Kuwait 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AZ - Azerbaigian 3
BH - Bahrain 3
BO - Bolivia 3
HR - Croazia 3
KG - Kirghizistan 3
KZ - Kazakistan 3
MD - Moldavia 3
NZ - Nuova Zelanda 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
BA - Bosnia-Erzegovina 2
BW - Botswana 2
BZ - Belize 2
CR - Costa Rica 2
EE - Estonia 2
GY - Guiana 2
IM - Isola di Man 2
IS - Islanda 2
OM - Oman 2
PS - Palestinian Territory 2
SN - Senegal 2
XK - ???statistics.table.value.countryCode.XK??? 2
BB - Barbados 1
BJ - Benin 1
Totale 30.862
Città #
Southend 1.849
Fairfield 1.588
Ashburn 1.502
Santa Clara 1.484
Hong Kong 1.186
Singapore 1.108
Chandler 1.015
Woodbridge 978
Houston 735
Seattle 618
Ann Arbor 554
Wilmington 540
Cambridge 528
Nyköping 514
Hefei 501
Jacksonville 434
Dearborn 399
Chicago 396
London 370
Beijing 363
Los Angeles 338
Modena 303
Seoul 238
New York 184
Salt Lake City 184
Helsinki 168
San Diego 164
Munich 128
Izmir 125
Princeton 123
Sofia 117
Ho Chi Minh City 112
The Dalles 110
Council Bluffs 108
Jakarta 108
Shanghai 103
Milan 96
Buffalo 94
Bologna 91
Tampa 87
Eugene 86
Moscow 83
Fremont 72
São Paulo 71
Elk Grove Village 67
Hanoi 67
Des Moines 63
Dallas 57
Bremen 53
Reggio Emilia 52
Turku 52
Brussels 46
Montreal 44
Redwood City 44
Falls Church 43
Rome 43
Frankfurt am Main 41
Shenzhen 41
Miami 40
Phoenix 40
Tokyo 40
Warsaw 38
Lancaster 37
Orem 37
Sterling 37
Dublin 36
Nuremberg 35
Toronto 35
Denver 33
Columbus 31
Dong Ket 31
Boardman 30
Ottawa 29
Falkenstein 28
Hillsboro 28
Johannesburg 28
Parma 27
Atlanta 26
Brooklyn 26
Sant'Ilario d'Enza 25
Florence 23
Guangzhou 23
Poplar 22
Rio de Janeiro 22
Detroit 21
Kent 21
Palermo 21
San Jose 21
Belo Horizonte 20
Chennai 20
Paris 20
Redondo Beach 20
Stockholm 20
Brasília 19
Brno 19
Manchester 19
Monmouth Junction 17
San Mateo 17
Verona 17
Hounslow 16
Totale 21.783
Nome #
Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms 500
c-Myb supports erythropoiesis through the transactivation of KLF1 and LMO2 expression. 458
Implementation of an NGS-based workflow for BRCA1 and BRCA2 mutation screening 410
c-Myb supports erythropoiesis by transactivating KLF1 and LMO2 expression 397
Virally mediated MafB transduction induces the monocyte commitment of human CD34+ hematopoietic stem/progenitor cells 389
Bone marrow-derived hematopoietic cells undergo myogenic differentiation following a Pax-7 independent pathway 380
C-Myb Restrains Megakaryopoiesis through the Hsa-MiR-486-3p-Driven Down-Regulation of C-Maf 377
Deregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cells 376
Involvement of MAF/SPP1 axis in the development of bone marrow fibrosis in PMF patients 376
Purinergic signaling inhibits human acute myeloblastic leukemia cell proliferation, migration, and engraftment in immunodeficient mice 375
The extracellular nucleotide UTP is a potent inducer of hematopoietic stem cell migration 363
miR-382-5p Controls Hematopoietic Stem Cell Differentiation Through the Downregulation of MXD1 356
Correlation between differentiation plasticity and mRNA expression profiling of CD34+-derived CD14- and CD14+ human normal myeloid precursors 353
MicroRNA expression profile in granulocytes from primary myelofibrosis patients 348
Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms' tumor gene 1 (WT1) 345
Unravelling the Complexity of Inherited Retinal Dystrophies Molecular Testing: Added Value of Targeted Next-Generation Sequencing 339
Co-culture of hematopoietic stem/progenitor cells with human osteblasts favours mono/macrophage differentiation at the expense of the erythroid lineage 338
Eosinophils, but not neutrophils, exibit an efficient DNA repair machinary and high nucleolar activity 335
Mutations and prognosis in primary myelofibrosis 335
miR-494-3p overexpression promotes megakaryocytopoiesis in primary myelofibrosis hematopoietic stem/progenitor cells by targeting SOCS6 332
The kinetic status of hematopoietic stem cell subpopulations underlies a differential expression of genes involved in self-renewal, commitment, and engraftment. 331
Molecular profile of CD34+ stem/progenitor cells according to JAK2V617F mutation status in essential thrombocythemia. 328
Transcriptional profiles in melanocytes from clinically unaffected skin distinguish the neoplastic growth pattern in patients with melanoma 326
Calreticulin Ins5 and Del52 mutations impair unfolded protein and oxidative stress responses in K562 cells expressing CALR mutants 323
Integrative Analysis Of mRNA/miRNA Expression Profiles Identified JARID2 As a Shared Target Of Deregulated Mirnas In Primary Myelofibrosis 322
miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells: role of miR-155/JARID2 axis in abnormal megakaryopoiesis 317
Identification of a molecular signature predictive of sensitivity to differentiation induction in acute myeloid leukemia 311
Analytic and Dynamic Secretory Profile of Patient-Derived Cytokine-Induced Killer Cells 310
Amplicon-based Next Generation Sequencing: an effective approach to molecular diagnosis of Epidermolysis Bullosa 310
Genomic landscape of megakaryopoiesis and platelet function defects 309
Calreticulin affects hematopoietic stem/progenitor cell fate by impacting erythroid and megakaryocytic differentiation 308
Purinergic stimulation of human mesenchymal stem cells potentiates their chemotactic response to CXCL12 and increases the homing capacity and production of proinflammatory cytokines 307
CALR mutational status identifies different disease subtypes of essential thrombocythemia showing distinct expression profiles 307
Antisense inhibition of c-fes proto-oncogene blocks PMA-induced macrophage differentiation in HL60 and in FDC-P1/MAC-11 cells 306
Amplicon-based next-generation sequencing: an effective approach for the molecular diagnosis of epidermolysis bullosa 305
Epidemiology and clinical relevance of mutations in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 359 patients of the AGIMM group 302
Abnormal expression patterns of WT1-as, MEG3 and ANRIL long non-coding RNAs in CD34+ cells from patients with primary myelofibrosis and their clinical correlations 301
Preclinical study for treatment of hypospadias by advanced therapy medicinal products 299
Role of miR-34a-5p in Hematopoietic Progenitor Cells Proliferation and Fate Decision: Novel Insights into the Pathogenesis of Primary Myelofibrosis 297
Role of TGF-β1/miR-382-5p/SOD2 axis in the induction of oxidative stress in CD34+ cells from primary myelofibrosis 295
Requirement of the coiled-coil domains of p92(c-Fes) for nuclear localization in myeloid cells upon induction of differentiation 290
Gene expression profile of vitamin D3 treated HL60 cells shows an incomplete molecular phenotypic conversion to monocytes 284
A data-driven network model of primary myelofibrosis: transcriptional and post-transcriptional alterations in CD34+ cells 280
Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study 279
Valproic acid triggers erythro/megakaryocyte lineage decision through induction of GFI1B and MLLT3 expression 273
Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patients 272
Isolation of human keratinocyte stem cells and high-throughput screening approach for their characterization 265
A functionally active RAR alpha nuclear receptor is expressed in retinoic acid non responsive early myeloblastic cell lines 264
Impact Of Prognostically Detrimental Mutations (ASXL1, EZH2, SRSF2, IDH1/2) On Outcomes In Patients With Myelofibrosis Treated With Ruxolitinib In COMFORT-II 253
Differential proteomic profile of leukemic CD34+ progenitor cells from chronic myeloid leukemia patients 250
Terminal differentiation 247
Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12low/neg accessory cells with dendritic-cell features 246
The isopeptidase inhibitor 2cPE triggers proteotoxic stress and ATM activation in chronic lymphocytic leukemia cells 246
Antiapoptotic effect of c-fes protooncogene during granulocytic differentiation 245
Bone marrow-specific loss of ABI1 induces myeloproliferative neoplasm with features resembling, human myelofibrosis 245
Expression And Function Of Nerve Growth-Factor And Nerve Growth-Factor Receptor On Cultured Keratinocytes. 243
Extracellular purines promote the differentiation of human bone marrow-derived mesenchymal stem cells to the osteogenic and adipogenic lineages 238
Wnt/CTNNB1 signal transduction pathway inhibits the expression of ZFP36 in squamous cell carcinoma, by inducing transcriptional repressors SNAI1, SLUG and TWIST 233
Development of an IL-6 antagonist peptide that induces apoptosis in IL-6 dependent 7TD1 cells. 232
Molecular and functional analysis of the stem cell compartment of chronic myelogenous leukemia reveals the presence of a CD34- cell population with intrinsic resistance to imatinib 230
Role of CD34 antigen in myeloid differentiation of human hematopoietic progenitor cells 228
Molecular and functional characterization of CD133+ stem/progenitor cells infused in patients with end-stage liver disease reveals their interplay with stromal liver cells 227
Characterisation and discovery of novel miRNAs and moRNAs in JAK2V617F mutated SET2 cells 225
All-trans-retinoic acid induces simultaneously granulocytic differentiation and expression of inflammatory cytokines in HL-60 cells 224
Expression of B7 costimulatory molecule in cultured human epidermal Langerhans cells is regulated at the mRNA level. 223
IDENTIFICATION OF A MOLECULAR SIGNATURE PREDICTIVE OF REFRACTORINESS IN ACUTE MYELOID LEUKEMIA 221
Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis 220
ANTISENSE STRATEGIES TO CHARACTERIZE THE ROLE OF GENES AND ONCOGENES INVOLVED IN MYELOID DIFFERENTIATION 219
Presence of a functional vitamin D receptor does not correlate with vitamin D3 phenotypic effects in myeloid differentiation 218
Mutated clones driving leukemic transformation are already detectable at the single-cell level in CD34-positive cells in the chronic phase of primary myelofibrosis 216
AMPLICON-BASED NGS: AN EFFECTIVE APPROACH FOR THE MOLECULAR DIAGNOSIS OF EPIDERMOLYSIS BULLOSA 215
IDENTIFICATION OF A MOLECULAR SIGNATURE PREDICTIVE OF REFRACTORINESS IN ACUTE MYELOID LEUKEMIA 214
BTK Inhibitors Impair Platelet-Mediated Antifungal Activity 214
Antisense strategies in leukemias 210
ROLE OF C-FES PROTOONCOGENE IN MYELOID DIFFERENTIATION 208
Genomic analysis of hematopoietic stem cell at the single-cell level: Optimization of cell fixation and whole genome amplification (WGA) protocol 208
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 205
Chromosome 9p trisomy increases stem cells clonogenic potential and fosters T-cell exhaustion in JAK2-mutant myeloproliferative neoplasms 203
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model 195
Cytokine-induced killer cells express CD39, CD38, CD203a, CD73 ectoenzymes and P1 adenosinergic receptors 193
The Response to Oxidative Damage Correlates with Driver Mutations and Clinical Outcome in Patients with Myelofibrosis 192
Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: Pathogenetic insight and diagnostic value 191
The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: An international study of 797 patients 189
Mechanistic insight into WEB-2170-induced apoptosis in human acute myelogenous leukemia cells. the crucial role of PTEN. 189
Characterization of new ATM deletion associated with hereditary breast cancer 188
SOX2 Is a Univocal Marker for Human Oral Mucosa Epithelium Useful in Post-COMET Patient Characterization 182
Physiological levels of 1 alpha, 25 di-hydroxyvitamin D3 induce the monocytic commitment of CD34+ hematopoietic progenitors 181
Tie2 expressing monocytes in the spleen of patients with primary myelofibrosis 181
Inhibition of c-fes expression by an antisense oligomer causes apoptosis oh HL60 cells induced to granulocytic differentiation 175
Gene Expression profile of Vitamin D3 treated HL60 cells shows a phenotypic but not a complete functional conversion to monocytes 174
Chromosome 9p Duplication Promotes T-Cell Exhaustion and Enhances Stem Cell Clonogenic Potential in JAK2-Mutant Myeloproliferative Neoplasms 171
ANTISENSE STRATEGIES IN LEUKEMIA 171
Automated capture-based NGS workflow: one thousand patients experience in a clinical routine framework 170
Prognostic Relevance of Multi-Antigenic Myeloma-Specific T-Cell Assay in Patients with Monoclonal Gammopathies 165
Ivar, an interpretation‐oriented tool to manage the update and revision of variant annotation and classification 165
MITOCHONDRIAL-DNA DELETION IN A PATIENT WITH PROGRESSIVE OPHTHALMOPLEGIA 164
Distribution of different classes of CSF3R mutations and co-mutational pattern in 360 myeloid neoplasia 161
Increased Plasma Levels of lncRNAs LINC01268, GAS5 and MALAT1 Correlate with Negative Prognostic Factors in Myelofibrosis 161
Integrative analysis of copy number and gene expression data suggests novel pathogenetic mechanisms in primary myelofibrosis 158
Novel Molecular Insights into Leukemic Evolution of Myeloproliferative Neoplasms: A Single Cell Perspective 157
Totale 26.582
Categoria #
all - tutte 129.681
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 129.681


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.873 0 0 0 0 0 249 214 341 175 429 269 196
2021/20222.630 136 228 299 162 124 153 137 151 265 196 430 349
2022/20233.118 379 406 297 272 333 409 67 284 345 44 143 139
2023/20242.073 81 91 171 177 325 177 303 252 41 72 117 266
2024/20256.651 178 65 120 395 1.226 933 603 449 741 287 827 827
2025/20266.828 807 473 882 1.510 2.356 800 0 0 0 0 0 0
Totale 31.124